Insights on interactions with pharma companies and real-world evidence from oncologists nationwide
Request our latest report
How can pharma companies deliver greater value to oncology practices?
What information sources do oncologists depend upon to learn about new therapies?
How is real-world evidence being used by oncologists when treating patients?
As the pace of oncology innovation accelerates, productive relationships between oncologists and the pharmaceutical industry have never been more important. In the latest edition of Oncology Insights, we explore oncologists’ views on interactions with pharmaceutical companies, as well as their understanding and use of real-world evidence. We share oncologists’ perspectives on:
The value of sales representative interactions and how pharma companies can address unmet needs for oncology practices
The channels oncologists rely upon to learn about new drugs and clinical news
Real-world evidence and how it’s being used to inform clinical decisions
Presented by Cardinal Health Specialty Solutions, this sixth edition features perspectives from more than 170 oncologists nationwide.